Home Cart 0 Sign in  
X

[ CAS No. 1283075-60-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1283075-60-4
Chemical Structure| 1283075-60-4
Chemical Structure| 1283075-60-4
Structure of 1283075-60-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1283075-60-4 ]

Related Doc. of [ 1283075-60-4 ]

Alternatived Products of [ 1283075-60-4 ]

Product Details of [ 1283075-60-4 ]

CAS No. :1283075-60-4 MDL No. :MFCD26402019
Formula : C7H3Cl2N3 Boiling Point : -
Linear Structure Formula :- InChI Key :BIULHHKFNLFURG-UHFFFAOYSA-N
M.W : 200.02 Pubchem ID :77231154
Synonyms :

Calculated chemistry of [ 1283075-60-4 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.35
TPSA : 38.67 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.06 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.57
Log Po/w (XLOGP3) : 2.06
Log Po/w (WLOGP) : 2.33
Log Po/w (MLOGP) : 1.25
Log Po/w (SILICOS-IT) : 2.73
Consensus Log Po/w : 1.99

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.99
Solubility : 0.203 mg/ml ; 0.00101 mol/l
Class : Soluble
Log S (Ali) : -2.5
Solubility : 0.631 mg/ml ; 0.00316 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.19
Solubility : 0.0128 mg/ml ; 0.0000641 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.85

Safety of [ 1283075-60-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1283075-60-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1283075-60-4 ]

[ 1283075-60-4 ] Synthesis Path-Downstream   1~15

  • 1
  • [ 131543-46-9 ]
  • [ 24484-99-9 ]
  • [ 1283075-60-4 ]
YieldReaction ConditionsOperation in experiment
In tetrahydrofuran; water; at 20℃; for 72h; A solution of of 4.81 g (27 mmol) <strong>[24484-99-9]4,6-dichloro-pyridine-2,3-diamine</strong> (synthesis described in J. E. Schelling, C. A. Salemink, Rec. Trav. Chim. Pays-Bas 91 , 650 [1972]) in 50 ml THF was treated with 5.22 g (27 mmol) of a 30percent solution of glyoxal in water and the mixture was stirred for 3 days at room temperature. The reaction mixture was evaporated and the residue was partitioned between dichloromethane and diluted sodium carbonate solution. The organic phase was dried over sodium sulfate and evaporated. The residue was chromatographed on a silica gel column with cyclohexane/ethyl acetate as eluent yielding 6,8-dichloro- pyrido[2,3-b]pyrazine as off-white fine needles; HPLC/MS (B): 1.93 min, [M+H] 200. 1H NMR (400 MHz, CDCI3) delta = 9.16 (d, J=1.7, 1 H), 9.05 (d, J=1.7, 1H), 7.89 (s, 1 H).
  • 2
  • [ 1283075-60-4 ]
  • [ 1993-03-9 ]
  • [ 1398057-29-8 ]
YieldReaction ConditionsOperation in experiment
With potassium hydrogencarbonate;bis-triphenylphosphine-palladium(II) chloride; In tetrahydrofuran; water; at 80.0℃; for 16h;Inert atmosphere; A solution of 1.60 g (8.00 mmol) <strong>[1283075-60-4]6,8-dichloro-pyrido[2,3-b]pyrazine</strong>, 1.12 g (8.00 mmol) 2-fluorophenylboronic acid and 961 mg (9.60 mmol) potassium hydrogen carbonate in 16 ml THF and 1.6 ml water was heated to 80 C under nitrogen. Then 112 mg (0.16 mmol) bis-(triphenylphosphine)-palladium(ll)-chloride were added and the mixture was stirred for 16 hrs at 80 C. Water was added to the reaction mixture and the precipitate was filtered off, dried in vacuum and recrystallized from 2-propanol: 8-chloro-6-(2-fluoro-phenyl)-pyrido[2,3-b]pyrazine as slightly yellow crystals; HPLC/MS (B): 2.68 min, [M+H] 260.H NMR (400 MHz, CDCI3) delta = 9.08 (d, J=1.7, 1H), 8.96 (d, J=1.7, 1H), 8.36 (d, =1.4, 1 H), 8.27 (td, J=7.9, 1.8, 1 H), 7.45 (m, 1 H), 7.28 (m, 1 H), 7.17 (ddd, J=11.6, 8.3, 0.8, 1H).
  • 3
  • [ 1283075-60-4 ]
  • [ 1398056-96-6 ]
  • 4
  • [ 1283075-60-4 ]
  • [ 1398057-31-2 ]
  • 5
  • [ 1283075-60-4 ]
  • [ 1398057-34-5 ]
  • 6
  • [ 1283075-60-4 ]
  • [ 1398056-99-9 ]
  • 7
  • [ 1283075-60-4 ]
  • [ 1398057-10-7 ]
  • 8
  • [ 1283075-60-4 ]
  • [ 1398057-18-5 ]
  • 9
  • [ 1283075-60-4 ]
  • [ 1398057-36-7 ]
  • 10
  • [ 1283075-60-4 ]
  • [ 1398057-16-3 ]
  • 11
  • [ 5049-61-6 ]
  • [ 1663-67-8 ]
  • [ 1283075-60-4 ]
  • 12
  • [ 1283075-60-4 ]
  • [ 1613289-27-2 ]
  • 13
  • [ 1283075-60-4 ]
  • [ 1613289-32-9 ]
  • 14
  • [ 1283075-60-4 ]
  • [ 1613289-49-8 ]
  • 15
  • [ 1283075-60-4 ]
  • [ 1613289-63-6 ]
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 1283075-60-4 ]

Pyridines

Chemical Structure| 2089292-97-5

[ 2089292-97-5 ]

5,7-Dichloro-2-methyl-1H-imidazo[4,5-b]pyridine

Similarity: 0.85